Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of PT010, PT009, and PT003 in Moderate to Very Severe COPD
NCT02536508Phase 3Completed
- Sponsor
- Pearl Therapeutics
- Start
- Aug 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Breztri Aerosphere in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Aug 2015; status: completed.
02
Drugs
Breztri Aerosphere
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02536508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02536508.